Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis.
about
Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic functionMicrotubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1Genome-wide characterisation of the binding repertoire of small molecule drugs.Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release.Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent.JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells.Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation.Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance.Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis.Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
P2860
Q24548364-46D413A4-E48C-4419-A23D-D68D046DD4A5Q24551023-05A76ADA-1A35-4106-B416-21C212CA3B2DQ24551055-BADAD771-8037-4BBA-81CC-E435CC67F7FAQ33209914-F8986F20-4C19-4D11-8B5E-01A8024AE2ABQ34086292-4340DF04-0002-481B-9F70-E0379FD2AC7AQ34247883-A93DA00C-7632-4928-83E3-31DBCEF07823Q34313121-7A065077-FE0B-49BF-A762-A85C7FD0961DQ34928995-8F0251E9-3F15-4080-8C31-429D844B4D18Q36670905-35E2DD54-2F99-4B72-B5ED-BB4A3054F609Q38733113-A407DEC5-FDE6-4BE1-B9A7-271595142AC2Q40440798-8F03916A-E1E6-4B8B-A9F8-F67371FE35B1Q40884725-E2916C88-F1DF-4190-B722-525725FD36CAQ42042886-63161513-CFF2-457C-AE62-1A1694D5B54DQ44359943-2382929A-F96A-419B-8525-688F3B3BA81BQ44905141-A08BDD1B-6340-44EF-979A-1E97BF57842C
P2860
Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Loss of the bcl-2 phosphorylat ...... ial dysfunction and apoptosis.
@en
Loss of the bcl-2 phosphorylat ...... stance of human leukemia cells
@nl
type
label
Loss of the bcl-2 phosphorylat ...... ial dysfunction and apoptosis.
@en
Loss of the bcl-2 phosphorylat ...... stance of human leukemia cells
@nl
prefLabel
Loss of the bcl-2 phosphorylat ...... ial dysfunction and apoptosis.
@en
Loss of the bcl-2 phosphorylat ...... stance of human leukemia cells
@nl
P2093
P356
P1476
Loss of the bcl-2 phosphorylat ...... ial dysfunction and apoptosis.
@en
P2093
P356
10.1006/BBRC.1999.0669
P407
P577
1999-05-01T00:00:00Z